by Briana Campbell (@MsMatchGirl)
Just the other day Richard Meyer posted an article entitled, “STOP! Social Media Is Not the Answer” in which he makes a strong case against pharma marketers turning to social media for their campaigns. He points out that people don’t want to connect with their drugs on social networks. He points out [...]
Tags:#hcsm·Facebook·Google·LinkedIn·marketing·Pharma·pharma marketing·Pharmaceutical industry·social·social media·Social network·social networking·Twitter
by Briana Campbell (@MsMatchGirl)
Wrath. Sloth. Greed. Gluttony. Lust. Envy. Pride.
The seven deadly sins.
In June of this year, PM360 laid out the Seven Deadly Sins of Pharma Marketing (you can take a peek at the digital edition here). And Dave Sonderman laid out his accompanying thoughts on the unintentional sins in a post on the GSW [...]
Tags:#hcmktg·#hcsm·communication·Communities·community·digital strategy·Digital Tools·Education·Facebook·FDA·Health·Health care·healthcare·information·marketing·Pharmaceutical industry·social media·social media platforms·social media strategies·Social network·strategy·Trends·Twitter
by Briana Campbell (@MsMatchGirl)
About a week and a half ago all the talk was about Facebook and its policy changes, disallowing pharmaceutical companies to turn off comments on their walls. Jonathan Richman ran a deathwatch over on Dose of Digital. The Washington Post had a story. We wrote about it, too. Seems like everyone did. [...]
Tags:communication·Communities·community·Facebook·FDA·FDA Guidance·John Mack·Jonathan Richman·NPR·Online community·Pharma·Pharma industry·Pharmaceutical industry·Pharmaguy·social media·Social network·social networks·user needs
by Briana Campbell (@MsMatchGirl)
The talk, for a long while now, has been about Facebook’s change of guidelines, no longer allowing pharmaceutical companies to turn off comments on their Facebook walls. Yesterday, D-Day arrived.
Over on Dose of Digital, Jonathan Richman, was keeping a “deathwatch” vigil over pages that were apt to be removed. On Friday, the [...]
Tags:communication·Communities·community·digital strategy·Digital Tools·engagement·Facebook·FDA·information·innovation·Legal Issues·Pharma·Pharmaceutical industry·social media·Social network·technology
This post is part of a series of point/counterpoint arguments proposed by different members of the Pixels & Pills staff. We’re strong believers that healthy arguments can yield the best solutions, and we hope that you enjoy our series. Feel free to add your own arguments in the comments section below!
by Krissy Goelz (@krisgoelz)
When it [...]
Tags:Facebook·FDA·marketing·patient·Patients·Pharma·Pharmaceutical industry·Rx·social media
by Briana Campbell (@MsMatchGirl)
A recent Pew Internet study, released June 16, 2011, shared the following statistic: Facebook users are overall more trusting than non-internet others. 43% of [study] participants were more likely than other internet users to feel that most people can be trusted.” With 51% of the American population over 12 years old on [...]
Tags:Communities·community·digital strategy·Education·Facebook·information·patient·Patients·Pharma·social media·Social network·user needs
by Krissy Goelz (@krisgoelz)
Oh, Facebook, how I love you so. Not because you’ve turned this city girl into a farmer or helped me get in touch with my inner Mafia Wars, but because you introduced me to the kind of engagement I want expect from my online experience. I’ve gotten to connect to the people [...]
Tags:communi·communication·Facebook·Google·Patients·social media·Social network·technology·Trends·User Experience·user needs
by DJ Edgerton (@wiltonbound)
It’s been several years now since the pharmaceutical industry first began to try to figure out social media – what it was, how to use it to find customers, how to give customers information, and how to learn more about them through it. It hasn’t been always successful, those several years, [...]
Tags:communication·Facebook·information·ph·physicians·social media
by Briana Campbell (@MsMatchGirl)
There has been a lot of talk, over the past few months, over Facebook’s changing commenting policies and the pharma industry. Our friend Jonathan Richman clears things up nicely on Dose of Digital, so we won’t bother going into too much detail here. Basically, though, Facebook has changed its policy regarding comments [...]
Tags:#hcsm·communication·Facebook·FDA·innovation·Legal Issues·marketing·Pharma·Pharmaceutical industry·social media·Social network·tools
Mary Kate Hallahan (@paliosaratoga)
Even though the Millennial Generation was practically born sending instant messages, commenting on blog posts, and connecting with strangers electronically, social media is still unchartered territory for many people – especially in the workplace.
There’s no denying the benefits of social media – instantaneous access to a wealth of information; availability of thought [...]
Tags:communication·digital strategy·Education·Facebook·social media·Social network·strategy·Trends
